[1]王慧,蓝弘毅,陆曙.名中医陆曙基于五维辨治理论诊治缺血性心肌病经验[J].陕西中医,2026,(2):242-247.[doi:DOI:10.3969/j.issn.1000-7369.2026.02.018]
　WANG Hui,LAN Hongyi,LU Shu.Famous physician LU Shu’s experience in diagnosing and treating ischemic cardiomyopathy based on the Five-dimensional differentiation and treatment theory[J].,2026,(2):242-247.[doi:DOI:10.3969/j.issn.1000-7369.2026.02.018]
点击复制

名中医陆曙基于五维辨治理论诊治缺血性心肌病经验

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2026年2期
页码:
242-247
栏目:
名中医经验
出版日期:
2026-02-05

文章信息/Info

Title:
Famous physician LU Shu’s experience in diagnosing and treating ischemic cardiomyopathy based on the Five-dimensional differentiation and treatment theory
作者:
王慧1; 蓝弘毅1; 陆曙2
（1.南京中医药大学研究生院，江苏 南京 210023；2.南京中医药大学附属无锡医院，江苏 无锡 214071）
Author(s):
WANG Hui1; LAN Hongyi1; LU Shu2
(1.Graduate School,Nanjing University of Chinese Medicine,Nanjing 210023，China;2.Wuxi Hospital Affiliated to Nanjing University of Chinese Medicine，Wuxi 214071，China)
关键词:
缺血性心肌病; 陆曙; 五维辨治; 五运六气; 冠状动脉粥样硬化
Keywords:
Ischemic cardiomyopathy; LU Shu; Five-dimensional differential diagnosis and treatment; Five phases and Six Qi theory; Coronary atherosclerosis
分类号:
R 542.2
DOI:
DOI:10.3969/j.issn.1000-7369.2026.02.018
文献标志码:
A
摘要:
缺血性心肌病（ICM）是冠状动脉粥样硬化终末阶段，是全球心力衰竭三大主因之一,已成为世界范围内发病率较高的疾病之一，其患病率及病死率呈上升趋势，现有药物-血运重建-器械综合策略仍存残余风险与再住院难题。中医药在增效减副、改善ICM患者症状、提高生活质量方面显示出独特价值。陆曙教授融合龙砂医派学术特色，创新性地提出涵盖“时效、质效、功效、药效、量效”的“五维辨治”诊疗体系。该体系以“司天、司人、司病症”为核心，系统整合了五运六气时空因素、个体体质差异、传统病证方证、现代药理研究及药物效价关系，旨在实现“五效合一”。时空维度从运气方、经方的时效性，并结合运气气化之开阖枢，从人体本质出发分析禀赋体质不同，结合病证不同发展阶段，药理角度以自拟方剂参芪养心汤为例，在药物效价角度参合药量，配伍及服药频次。并展示了如何基于此五维框架，灵活运用经方、时方及自拟方，显著改善患者心功能、缓解症状并提升生活质量。单维或多维共用来诊治ICM，为ICM的个体化、精准化治疗提供了富有启发的系统思路和可操作的临床范式，以期全面有效，同时也为其他疾病的中西医结合诊治提供了系统化的创新路径。
Abstract:
Ischemic cardiomyopathy (ICM) was the terminal stage of coronary atherosclerosis and one of the three major causes of heart failure worldwide.It has become one of the diseases with a relatively high incidence rate globally,and its prevalence and mortality rate were on the rise.The current comprehensive strategy of drugs,revascularization,and devices still has residual risks and problem of rehospitalization.Traditional Chinese medicine has shown unique value in enhancing efficacy,reducing side effects,improving symptoms of ICM patients,and improving their quality of life.Professor LU Shu,integrating the academic characteristics of the Longsha School of medicine,innovatively proposed a five-dimensional diagnosis and treatment system covering time-effect,quality-effect,function-effect,drug-effect,and dosage-effect.This system takes heavenly Qi,human constitution,and disease symptoms as its core,systematically integrating the temporal and spatial factors of the Five-Elements and Six Qi,individual constitutional differences,traditional disease and syndrome differentiation,modern pharmacological research,and the relationship between drug dosage and efficacy,aiming to achieve five effects in one.The temporal and spatial dimension analyzes the timeliness of traditional and seasonal prescriptions,and combines the opening,closing,and pivot of the Qi transformation of Five-Elements and Six Qi,starting from the essence of the human body to analyze the differences in endowment and constitution,and combines the different stages of disease development.From the pharmacological perspective,taking the self-prescribed prescription Shenqi Yangxin decoction as an example,it considers the dosage,compatibility,and frequency of administration from the perspective of drug efficacy.It also demonstrates how to flexibly apply classic prescriptions,seasonal prescriptions,and self-prescribed prescriptions based on this five-dimensional framework to significantly improve patients’ cardiac function,alleviate symptoms,and enhance their quality of life.The use of single or multiple dimensions for the diagnosis and treatment of ICM provides a systematic and operational clinical model for individualized and precise treatment of ICM,aiming for comprehensive and effective results.It also offers a systematic and innovative path for the integrated diagnosis and treatment of other diseases in both traditional Chinese and Western medicine.

参考文献/References:

[1]文倩,何嘉俊,刘伟涛,等.沙库巴曲缬沙坦钠对缺血性心肌病型冠心病患者血管内皮功能、心室重构、心功能及生活质量的影响研究[J].陕西医学杂志,2025,54(4):529-533.
[2]YANG X,ZHAO Z P,SHI Y,et al.The evolving burden of heart failure in China:A 34-year subnational analysis of trends and causes from the global burden of disease study 2023[J].Mil Med Res,2025,12(1):65.
[3]MORONI F,GERTZ Z,AZZALINI L.Relief of ischemia in ischemic cardiomyopathy[J].Curr Cardiol Rep,2021,23(7):80.
[4]RYAN M,MORGAN H,PETRIE M C,et al.Coronary revascularisation in patients with ischaemic cardiomyopathy[J].Heart,2021,107(8):612-618.
[5]马育鹏,郑文娇,马琳.基础治疗联合舒心通脉胶囊防治冠心病进展为缺血性心肌病的临床效果[J].中外医药研究,2025,4(13):82-84.
[6]姜国旺,生晓迪,邓帅帅,等.虫类药在缺血性心肌病中应用的研究进展[J].中西医结合心脑血管病杂志,2024,22(15):2770-2773.
[7]胡勇,杨波,许方雷.保元汤合桃红饮方联合琥珀酸美托洛尔治疗老年缺血性心肌病心力衰竭的疗效[J].中西医结合心脑血管病杂志,2025,23(16):2506-2509.
[8]陆曙,陶国水.龙砂医派五维辨治体系构建及其学术内涵[J].江苏中医药,2025,57(11):1-5.
[9]中华中医药学会.中医内科临床诊疗指南[M].北京:中国中医药出版社：77-110.
[10]陆曙,陶国水,顾植山.基于《黄帝内经》五运六气学说的临床思维构建[J].中华中医药学刊,2020,38(4):25-28.
[11]蓝弘毅,陆曙,陶国水.运气学说的现代研究进展[J].中医药导报,2025,31(8):165-170.
[12]陆曙,陶国水,顾植山.基于《黄帝内经》五运六气理论的临证处方策略[J].中华中医药杂志,2020,35(2):565-568.
[13]吴俊达,姚俊杰,孙雅蕙,等.基于五运六气及气象特征探讨长春地区老年脑梗死患者发病规律[J].长春中医药大学学报,2025,41(8):876-882.
[14]常磊,卢雯平,崔永佳,等.基于五运六气理论对1099例子宫内膜癌患者禀赋特征的研究[J].广州中医药大学学报,2025,42(5):1072-1077.
[15]姚俊杰,丛德毓,常天瀛,等.基于《黄帝内经》运气理论探析长春地区腰椎间盘突出症发病规律与气象因素的相关性[J].中华中医药杂志,2025,40(5):2636-2641.
[16]郝宇,贺娟.五运六气禀赋特征与恶性肿瘤罹患的关联性研究述评[J].中华中医药杂志,2025,40(3):1003-1008.
[17]戴超俊,李翠云,林超,等.缺血性心肌病患者中医证型、心功能、血清人可溶性生长刺激表达基因蛋白2水平的相关性[J].中医杂志,2019,60(21):1827-1831.
[18]李震,晋群.炎症在冠心病发生发展中的作用及抗炎治疗研究进展[J].陕西医学杂志,2025,54(7):1001-1009.
[19]施敏,魏佳明,袁惠,等.黄芪活性成分治疗心力衰竭作用机制的研究进展[J].中国实验方剂学杂志,2024,30(3):208-217.
[20]李梦华,张瓅方.黄芪丹参配伍提取物在大鼠缺血性心肌中的调控作用及机制[J].科学技术与工程,2020,20(31):12759-12763.
[21]高源,彭丹冰,方灿,等.太子参抗心肌缺血作用机制的网络药理学研究[J].世界科学技术-中医药现代化,2020,22(9):3216-3224.
[22]陈志国,杜瑞娟,卞华.麦冬皂苷D抗心血管疾病作用机制研究进展[J].中成药,2023,45(9):2978-2986.
[23]张阳阳,孙琮,杨兴嫕,等.炙甘草汤加减联合依那普利治疗慢性阻塞性肺疾病合并心力衰竭疗效研究[J].陕西中医,2021,42(9):1219-1222.
[24]邢楠楠,屈怀东,任伟超,等.五味子主要化学成分及现代药理作用研究进展[J].中国实验方剂学杂志,2021,27(15):210-218.
[25]郭道华,韦颖梅,王小静,等.白芍总苷对大鼠心肌缺血再灌注损伤保护作用及对GRP78表达的影响[J].中西医结合心脑血管病杂志,2010,8(5):556-558.
[26]于辉,赵阳,费家玥,等.异甘草素抑制SETD7表达可保护缺氧/复氧诱导心肌细胞的氧化损伤[J].中国组织工程研究,2020,24(35):5613-5618.
[27]陆曙,张寄南.黄芪的心血管药理作用研究进展[J].中草药,1998,29(1):59-61.
[28]陶国水,孔令晶,陆曙.陆曙诊治心系疾病学术经验探赜[J].中华中医药杂志,2024,39(10):5309-5313.
[29]孔令晶,陆曙,陶国水.陆曙基于五维辨治诊治顽固性失眠经验[J].中医药临床杂志,2025,37(4):676-680.
[30]詹里成.五运六气理论指导治案举隅[J].实用中医药杂志,2025,41(9):1888-1890.

备注/Memo

备注/Memo:
国家自然科学基金资助项目（82274427）；国家中医药管理局陆曙全国名老中医药专家传承工作室建设项目（国中医药办人教函〔2022〕75号）；第七批全国老中医药专家学术经验继承工作项目（国中医药人教函〔2022〕76号）；江苏省中医流派研究院开放课题（JSZYLP2024027）
更新日期/Last Update: 2026-02-09